TrialBMC gastroenterology2014

Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C.

Lucia Flores-Contreras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.